EOM Pharmaceutical Holdings, Inc. (OTCMKTS:IMUC – Get Free Report)’s stock price shot up 139% during trading on Monday . The company traded as high as $0.2180 and last traded at $0.2180. 12,218 shares traded hands during trading, an increase of 535% from the average session volume of 1,924 shares. The stock had previously closed at $0.0912.
EOM Pharmaceutical Trading Down 35.5%
The firm has a fifty day moving average of $0.16 and a 200 day moving average of $0.11.
EOM Pharmaceutical Company Profile
EOM Pharmaceutical, trading under the ticker OTCMKTS:IMUC, is a clinical-stage biotechnology company focused on the development of cell-based immunotherapies for the treatment of solid tumors. The company leverages dendritic cell technology to create personalized therapeutic vaccines designed to activate a patient’s immune system against tumor-specific antigens. By harnessing key insights into antigen presentation and T-cell activation, EOM Pharmaceutical aims to improve survival outcomes for patients with cancers that currently have limited treatment options.
The company’s lead programs are directed at glioblastoma multiforme and other aggressive tumor types, where standard therapies often fall short.
Read More
- Five stocks we like better than EOM Pharmaceutical
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for EOM Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
